Bio News
A new immune-evasion pathway in which dengue virus infects and replicates in memory B cells has been identified for the first time. All four virus types use this pathway, which differs from the previously known mechanism of antibody-dependent enhancement (ADE). The finding could enable the development of strategies to apply B-cell-targeting drugs used to treat cancer to dengue treatment.
Biobook Team
biobookmedia@biobook.co.krRoche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027
BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
